Sivik Global Healthcare’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-57,500
| Closed | -$5.02M | – | 39 |
|
2024
Q1 | $5.02M | Buy |
57,500
+2,500
| +5% | +$218K | 1.18% | 27 |
|
2023
Q4 | $5.3M | Buy |
55,000
+5,000
| +10% | +$482K | 2.22% | 25 |
|
2023
Q3 | $4.42M | Hold |
50,000
| – | – | 2.24% | 26 |
|
2023
Q2 | $4.33M | Hold |
50,000
| – | – | 1.01% | 31 |
|
2023
Q1 | $4.86M | Sell |
50,000
-10,000
| -17% | -$972K | 2.09% | 25 |
|
2022
Q4 | $6.21M | Buy |
60,000
+5,000
| +9% | +$517K | 2.92% | 14 |
|
2022
Q3 | $4.66M | Buy |
55,000
+7,500
| +16% | +$636K | 2.59% | 21 |
|
2022
Q2 | $3.94M | Buy |
47,500
+7,500
| +19% | +$621K | 2.24% | 22 |
|
2022
Q1 | $3.08M | Hold |
40,000
| – | – | 1.27% | 38 |
|
2021
Q4 | $3.53M | Sell |
40,000
-25,000
| -38% | -$2.21M | 1.51% | 31 |
|
2021
Q3 | $5.02M | Buy |
65,000
+10,000
| +18% | +$773K | 1.2% | 30 |
|
2021
Q2 | $4.59M | Sell |
55,000
-5,000
| -8% | -$417K | 0.9% | 31 |
|
2021
Q1 | $4.53M | Sell |
60,000
-20,000
| -25% | -$1.51M | 1.65% | 31 |
|
2020
Q4 | $7.02M | Buy |
80,000
+15,000
| +23% | +$1.32M | 2.86% | 15 |
|
2020
Q3 | $4.95M | Sell |
65,000
-155,000
| -70% | -$11.8M | 2.13% | 27 |
|
2020
Q2 | $8.13M | Sell |
220,000
-15,000
| -6% | -$554K | 2.69% | 15 |
|
2020
Q1 | $8.39M | Buy |
235,000
+155,000
| +194% | +$5.53M | 3.31% | 9 |
|
2019
Q4 | $6.76M | Buy |
80,000
+35,000
| +78% | +$2.96M | 2.51% | 17 |
|
2019
Q3 | $3.03M | Buy |
45,000
+10,000
| +29% | +$674K | 1.53% | 35 |
|
2019
Q2 | $3M | Sell |
35,000
-10,000
| -22% | -$857K | 0.72% | 43 |
|
2019
Q1 | $4M | Sell |
45,000
-10,000
| -18% | -$888K | 1.47% | 32 |
|
2018
Q4 | $4.68M | Hold |
55,000
| – | – | 2.52% | 16 |
|
2018
Q3 | $5.33M | Sell |
55,000
-10,000
| -15% | -$970K | 1.9% | 23 |
|
2018
Q2 | $6.12M | Buy |
65,000
+45,000
| +225% | +$4.24M | 2.35% | 15 |
|
2018
Q1 | $1.62M | Sell |
20,000
-55,000
| -73% | -$4.46M | 0.76% | 56 |
|
2017
Q4 | $6.69M | Hold |
75,000
| – | – | 2.48% | 9 |
|
2017
Q3 | $6.98M | Sell |
75,000
-10,000
| -12% | -$931K | 2.37% | 17 |
|
2017
Q2 | $7.72M | Buy |
85,000
+30,000
| +55% | +$2.72M | 2.83% | 6 |
|
2017
Q1 | $4.83M | Sell |
55,000
-5,000
| -8% | -$439K | 2.25% | 17 |
|
2016
Q4 | $4.97M | Sell |
60,000
-10,000
| -14% | -$828K | 2.37% | 18 |
|
2016
Q3 | $6.48M | Buy |
70,000
+30,000
| +75% | +$2.78M | 3.27% | 10 |
|
2016
Q2 | $3.11M | Sell |
40,000
-20,000
| -33% | -$1.56M | 1.55% | 34 |
|
2016
Q1 | $4.95M | Buy |
60,000
+32,114
| +115% | +$2.65M | 2.19% | 18 |
|
2015
Q4 | $2.92M | Sell |
27,886
-7,114
| -20% | -$745K | 1.39% | 33 |
|
2015
Q3 | $3.69M | Buy |
35,000
+10,000
| +40% | +$1.05M | 1.79% | 23 |
|
2015
Q2 | $3.42M | Sell |
25,000
-10,000
| -29% | -$1.37M | 1.19% | 31 |
|
2015
Q1 | $4.36M | Buy |
35,000
+5,200
| +17% | +$648K | 1.48% | 29 |
|
2014
Q4 | $2.69M | Buy |
29,800
+9,800
| +49% | +$886K | 1.09% | 46 |
|
2014
Q3 | $1.44M | Buy |
+20,000
| New | +$1.44M | 0.66% | 57 |
|
2014
Q1 | – | Sell |
-12,000
| Closed | -$844K | – | 69 |
|
2013
Q4 | $844K | Buy |
+12,000
| New | +$844K | 0.6% | 53 |
|